🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9 results for “Silence” Clear

  1. Atu027 & gemcitabine in lead in safety period

    Silence Therapeutics plc

    Carcinoma, Pancreatic Ductal

    phase 2 small molecule completed

    1 trial

  2. Phase 1b/2 trial of 5-fluorouracil, leucovorin, irinotecan in combination with temozolomide (FLIRT) and bevacizumab for the first-line treatment of patients with MGMT silenced, microsatellite stable metastatic colorectal cancer.

    Fondazione Telethon ETS

    metastatic colorectal cancer

    phase 2 other active

    1 trial

  3. SLN124

    Silence Therapeutics plc

    Polycythemia Vera

    phase 2 small molecule active

    1 trial

  4. SLN360

    Silence Therapeutics plc

    Cardiovascular Diseases

    phase 2 small molecule completed

    1 trial

  5. Atu027

    Silence Therapeutics plc

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  6. SLN124

    Silence Therapeutics plc

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  7. SLN124

    Silence Therapeutics plc

    Non-transfusion-dependent Thalassemia

    phase 1 small molecule completed

    1 trial

  8. SLN124 is a GalNAc conjugated double stranded fully modified siRNA. Sodium chloride 0.9% w/v is used as Placebo

    Silence Therapeutics plc

    Non-transfusion-dependent Thalassemia

    phase 1 small molecule terminated

    1 trial

  9. SLN360

    Silence Therapeutics plc

    Hyperlipidemias

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources